Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
226
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
+3.5M
-
Total reported value, excl. options
-
$4.8B
-
Value change
-
+$143M
-
Put/Call ratio
-
0.39
-
Number of buys
-
132
-
Number of sells
-
-109
-
Price
-
$40.86
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2021
289 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q2 2021.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 226 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 152M outstanding shares and own 77.32% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), Matrix Capital Management Company, LP (11.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11M shares), VANGUARD GROUP INC (10.2M shares), BlackRock Inc. (5.32M shares), ARK Investment Management LLC (4.37M shares), Neuberger Berman Group LLC (2.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.15M shares), GILDER GAGNON HOWE & CO LLC (2.05M shares), and Capital International Investors (1.96M shares).
This table shows the top 226 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.